Parkman Healthcare Partners LLC Axsome Therapeutics, Inc. Transaction History

Parkman Healthcare Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$55.91 - $81.44 $1.72 Million - $2.5 Million	-30,758 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$66.31 - $86.52 $281,950 - $367,883	-4,252 Reduced 12.15%	30,758 $2.51 Million
Q3 2020 Nov 13, 2020	SELL	$68.34 - $85.84 $341,016 - $428,341	-4,990 Reduced 12.48%	35,010 $2.49 Million
Q2 2020 Aug 13, 2020	BUY	$49.87 - $98.69 $1.99 Million - $3.95 Million	40,000 New	40,000 $3.29 Million

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.43B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.